Showing results (631-640 of 903) with videos related to

Sort By:
Pageof 91
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Deutsches Arzteblatt International|August 1, 2022
Metamizole-Associated Risks in Decompensated Hepatic CirrhosisBenjamin Schulte, Tammo L Tergast, Marie Griemsmann, et al.
Hepatology (Baltimore, Md.)|February 21, 2024
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signatureSophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz, et al.
Intervirology|December 2, 2015
Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial AssaysSven Pischke, Carolynne Schwarze-Zander, Birgit Bremer, et al.
Journal of Hepatology|June 26, 2013
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinomaTamar Kapanadze, Jaba Gamrekelashvili, Chi Ma, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2006
Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantationGabriele I Kirchner, Kinan Rifai, Tobias Cantz, et al.
The Journal of Clinical Investigation|March 19, 2005
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injuryTom Luedde, Ulrike Assmus, Torsten Wüstefeld, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor developmentSilke Marhenke, Jutta Lamlé, Laura Elisa Buitrago-Molina, et al.
Pageof 91